Related Experiment Video
Updated: Aug 16, 2026

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
Published on: September 19, 2016
Efficacy of pertussis vaccines: a brighter horizon
Insights
Recent pertussis vaccines are more effective than older ones, offering better protection against various Bordetella pertussis serotypes. Optimal immunization schedules and vaccines containing all three pertussis agglutinogens are crucial for preventing infections.
Area of Science:
- Pediatrics
- Immunology
- Microbiology
Background:
- Pertussis (whooping cough) remains a significant childhood illness.
- Vaccine effectiveness can vary based on manufacturing date and circulating Bordetella pertussis serotypes.
Purpose of the Study:
- To evaluate the effectiveness of pertussis vaccines manufactured before and after 1967.
- To identify predominant Bordetella pertussis serotypes and factors influencing serotype changes during infection.
Main Methods:
- Analysis of pertussis infections in 186 children under 11 years old.
- Comparison of vaccine effectiveness based on manufacturing dates and Bordetella pertussis serotypes.
Main Results:
- Vaccines manufactured from 1967 onwards showed improved effectiveness against diverse Bordetella pertussis serotypes compared to earlier vaccines.
- Four doses of recent vaccine were associated with a low incidence of positive cultures.
- Simultaneous infections with multiple serotypes were common, with type 1,3 being predominant.
Conclusions:
- Modern pertussis vaccines demonstrate broader efficacy across different serotypes.
- Adequate immunization schedules and vaccines containing all three pertussis agglutinogens are essential for effective pertussis prevention.
Abstract:
A study of pertussis infections in 186 children under 11 years of age in the Manchester region during 1969-71 suggests that recently-manufactured vaccines have been more effective than those made before 1967. The earlier vaccines were effective mainly against the serotypes of Bordetella pertussis possessing antigen 2, while those made from 1967 are more nearly equal in their effectiveness against thedi fferent serotypes. A booster dose of the earlier vaccines did not prevent infection with type 1,3 organisms, but we obtained a positive culture from only one child who had received four doses of recent vaccine.Simultaneous infection of a child with two or more serotypes was frequently seen. The predominant serotype in a patient was usually type 1,3; less often it was type 1,2,3 or type 1,2; it was never type 1. A change of serotype sometimes occurs during the course of the illness and is probably directed by the vaccination status of the patient in relation to the serotype of the initial infection.Our findings emphasize the need for vaccines to contain adequate amounts of all three pertussis agglutinogens, and for satisfactory immunization schedules to be used in their administration.
Related Concept Videos
Vaccinations
Microorganisms in Medicine and Therapeutics
Vaccines
Smallpox
Poliomyelitis
Respiratory Syncytial Virus Disease

